country

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

TLR9 - toll like receptor 9 Gene

Species: Sus scrofa

Gene Type: protein coding

Gene ID: 397007

About TLR9

Primary_assembly 13: 34,349,609-34,357,673 reverse strand.Sscrofa11.1:CM000824.5

This gene has 1 transcript (splice variant), 81 orthologues and 24 paralogues. Ubiquitous expression in heart (RPKM 22.2), spleen (RPKM 17.3) and 8 other tissues.

TLR9 Products (2)

mRNA	Protein	Name
NM_213958.1	NP_999123.1	toll-like receptor 9 precursor
NM_213958.1	NP_999123.1	toll-like receptor 9 precursor

TLR9 Protein Structure

ADF_Twf-N_like

ADF_Twf-C_like

PRK15370

LRR_RI

PLN00113

LRR_RI

LRR_8

LRR_RI

TIR_2

0
300
600
900
1200
1323 a.a.

Protein Preferred Names	Protein Names
toll-like receptor 9

Related Agents

Approval
Clinical Phase
Pre-clinical Phase

Approval

Bioactive Molecules (3)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-B1370	Hydroxychloroquine sulfate	Inhibitor	99.99%	Yes
HY-B1370B	(R)-Hydroxychloroquine	Inhibitor	/	Unkown
HY-B1370A	(S)-Hydroxychloroquine	Inhibitor	/	Unkown

Clinical Phase

Bioactive Molecules (8)

Cat. No.	Product Name	Effect	Purity	Phase
HY-150218	Agatolimod sodium	Agonist	99.13%	Phase 3
HY-150212	Tilsotolimod	Inhibitor	99.46%	Phase 3
HY-148511	Vidutolimod	Agonist	93.85%	Phase 3
HY-150724C	ODN 1018 sodium	Agonist	97.49%	Phase 2
HY-150724	ODN 1018	Agonist	99.28%	Phase 2
HY-177617A	Bazlitoran sodium	Agonist	95.30%	Phase 2
HY-177617	Bazlitoran	Agonist	95.30%	Phase 2
HY-178166	ETI41	Inhibitor	/	Phase 1

Pre-clinical Phase

Bioactive Molecules (33)

Cat. No.	Product Name	Effect	Purity	Rare Diseases
HY-146245	ODN 1826	Agonist	99.69%	Unkown
HY-146245C	ODN 1826 sodium	Agonist	99.51%	Unkown
HY-146244	Agatolimod	Agonist	98.84%	Unkown
HY-150741C	ODN 2216 sodium	Agonist	98.57%	Unkown
HY-150741	ODN 2216	Agonist	98.57%	Unkown
HY-N0201	Atractylenolide I	Antagonist	99.98%	Unkown
HY-150743	ODN 2395	Agonist	98.39%	Unkown
HY-150726C	ODN 1668 sodium	Agonist	98.79%	Unkown
HY-124603	AT791	Inhibitor	98.77%	Unkown
HY-150743C	ODN 2395 sodium	Agonist	98.20%	Unkown
HY-148045	TLR9-IN-1	Inhibitor	99.67%	Unkown
HY-12756	E6446	Antagonist	98.78%	Unkown
HY-150726	ODN 1668	Agonist	99.03%	Unkown
HY-12756A	E6446 dihydrochloride	Antagonist	99.29%	Unkown
HY-150750	ODN M362	Agonist	96.01%	Unkown
HY-150217A	CpG ODN 10101 sodium	Agonist	98.84%	Unkown
HY-150217	CpG ODN 10101	Agonist	99.44%	Unkown
HY-B1370R	Hydroxychloroquine sulfate (Standard)	Inhibitor	99.96%	Unkown
HY-101929	CU-CPT17e	Agonist	98.67%	Unkown
HY-150736	ODN 20844	Inhibitor	96.14%	Unkown
HY-146245F	FAM-labeled ODN 1826 sodium	Agonist	98.03%	Unkown
HY-114592	M199	Inhibitor	98.55%	Unkown
HY-150744	ODN 24888	Inhibitor	/	Unkown
HY-150745	ODN 24987	Inhibitor	/	Unkown
HY-178037	TLR9 antagonist 1	Antagonist	/	Unkown
HY-179474	TSI-13-57	Inhibitor	98.73%	Unkown
HY-150219A	ODN M326 sodium	Inhibitor	/	Unkown
HY-180507	TLR2/9 antagonist 1	Antagonist	/	Unkown
HY-179209	TLR9-IN-2	Inhibitor	/	Unkown
HY-178169	ETI60	Inhibitor	99.51%	Unkown
HY-150219	ODN M326	Agonist	/	Unkown
HY-183079	ENDO12	Inhibitor	/	Unkown
HY-183400	BIM-46174	Inhibitor	/	Unkown

Orthologs Information

Species	Symbol	Source	ID
Homo sapiens	TLR9	NCBI	NCBI:54106